Pediatric Septic Arthritis and Osteomyelitis in the USA: A National KID Database Analysis

Gabriella Safdieh1, Jason Silberman2, Joseph Nguyen3

  • 1Parsley Health, 33 Irving Place, New York, NY 10003 USA.

Insights

Pediatric osteomyelitis and combined infections incidence rose, while septic arthritis remained stable. Despite consistent length of stay, healthcare costs for these pediatric infections significantly increased from 1997 to 2012.

Area of Science:

  • Pediatric infectious diseases
  • Healthcare epidemiology
  • Musculoskeletal infections

Background:

  • Osteoarticular infections in children may be rising.
  • Understanding trends in pediatric osteomyelitis and septic arthritis is crucial.

Purpose of the Study:

  • To analyze changes in incidence rates, costs, and length of stay for pediatric osteomyelitis, septic arthritis, and combined infections.
  • To compare current pediatric infection rates with previous findings.

Main Methods:

  • Utilized the Kids' Inpatient Database (KID) from 1997-2012 for pediatric discharge records.
  • Calculated yearly incidence rates using US census data.
  • Employed trend tests to assess changes in length of stay and inflation-adjusted costs over time.

Main Results:

  • Osteomyelitis incidence increased from 7.9 to 10.5 per 100,000; combined infections rose from 0.8 to 1.3 per 100,000.
  • Septic arthritis incidence remained stable at approximately 5.2-5.3 per 100,000.
  • Median length of stay showed no significant change, but median in-hospital costs increased substantially for all infection types.

Conclusions:

  • Pediatric septic arthritis incidence is stable, while osteomyelitis and combined infection rates have increased.
  • Observed pediatric infection rates align with prior reports.
  • Despite stable length of stay, healthcare costs for pediatric osteoarticular infections have risen over time.
Abstract

Related Concept Videos

National Nursing Organizations I01:26

National Nursing Organizations I

Nursing organizations assume a significant role in consistently developing the nursing profession through education, research studies, establishing practice standards, and reforming health policies. Typically, nursing organizations operate at the regional, national, and international levels. For example, the International Council of Nurses (ICN) represents more than 28 million nurses worldwide. In contrast, the American Nurses Association (ANA) is a membership organization representing nurses...
3.0K
National Nursing Organizations II01:30

National Nursing Organizations II

Nursing organizations play a vital role in representing nurses working in specialized clinical settings, such as the American Association of Critical-Care Nurses (AACN).
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
257